Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

Alba Muzzi, Gioacchino Leandro, Laura Rubbia-Brandt, Richard James, Olivia Keiser, Raffaele Malinverni, Jean François Dufour, Beat Helbling, Antoine Hadengue, Jean Jacques Gonvers, Beat Müllhaupt, Andreas Cerny, Mario U. Mondelli, Francesco Negro

Research output: Contribution to journalArticlepeer-review


Liver steatosis is a frequent finding in chronic hepatitis C. An association has been suggested between steatosis and fibrosis progression rate, but the pathogenetic mechanisms linking fatty infiltration and collagen deposition are unknown. We measured the levels of insulin resistance (as HOMA score) and leptin in 221 non-diabetic chronic hepatitis C patients, to assess their impact on liver steatosis and fibrosis, relative to other factors, using a multivariable logistic regression. When all 221 patients were considered, steatosis was associated with excessive alcohol intake, genotype 3, and serum HCV RNA level, whereas fibrosis was associated with HOMA score and age. In 152 patients infected with genotype non-3, steatosis was associated with alcohol abuse and HCV RNA level, and fibrosis with HOMA score and age. In the 69 patients with genotype 3, steatosis and fibrosis were associated with each other. The association between fibrosis and HOMA score held also when 22 obese patients were excluded from the analysis. Levels of insulin resistance were not correlated with the presence of steatosis. Thus, insulin resistance (but not leptin) may play a role in fibrogenesis in chronic hepatitis C patients infected with genotype non-3.

Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalJournal of Hepatology
Issue number1
Publication statusPublished - Jan 2005


  • Diabetes
  • Hepatitis C virus
  • Insulin resistance
  • Leptin
  • Liver fibrogenesis
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients'. Together they form a unique fingerprint.

Cite this